“As one of only 10 license holders in a state with a population of approximately 20 million, this acquisition is firmly in line with our strategic goal of entering highly regulated markets to manufacture and distribute cannabis brands at scale,” GTI CEO Ben Kovler said in a public statement.

See a list of the state’s 10 licensed businesses here.

Read full report at https://www.cannabisbusinesstimes.com/article/gti-green-thumb-industries-acquires-fiorello-pharmaceuticals-new-york/